To boost India’s R&D spend toward 3% of GDP, ANRF CEO Shivkumar Kalyanaraman revealed a patient-capital architecture combining private investment, open IP licensing, and national mission programmes.
To boost India’s R&D spend toward 3% of GDP, ANRF CEO Shivkumar Kalyanaraman revealed a patient-capital architecture combining private investment, open IP licensing, and national mission programmes.
<iframe src="https://hindustansphere.com/embed/cluster/376ae5f5e3123280ee1a8e7340945aa6ce2e3645" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="‘We cannot wait 75 years’: ANRF CEO Shivkumar Kalyanaraman on scaling India’s research multiplier"></iframe>
